{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Surgery Partners, Inc.
Surgery Partners Faces Weak Start with 21.85% Gap Down Amid Market Concerns
Surgery Partners, Inc. experienced a significant stock decline today, reflecting broader market challenges. The company, with a market capitalization of USD 2,010 million and a price-to-earnings ratio of 30.00, has shown mixed technical indicators and a moderate level of leverage, as evidenced by its debt-to-equity ratio of 1.46.
Surgery Partners, Inc. Stock Plummets to New 52-Week Low at $12.25
Surgery Partners, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,010 million, has faced financial challenges, including a substantial net profit loss and a high debt-to-equity ratio.
Surgery Partners, Inc. Experiences Revision in Stock Evaluation Amid Market Volatility
Surgery Partners, Inc., a small-cap hospital industry company, has seen its stock price rise slightly to $15.49 amid significant volatility over the past year. The stock has faced challenges, declining 39.66% compared to the S&P 500's gain, reflecting ongoing struggles in a competitive market.
Surgery Partners, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Variability
Surgery Partners, Inc. has recently revised its evaluation amid fluctuating market conditions. The stock, currently priced at $22.90, has shown volatility over the past week. While it outperformed the S&P 500 recently, its yearly performance indicates underachievement compared to the broader index, reflecting its competitive market positioning.
Is Surgery Partners, Inc. technically bullish or bearish?
As of October 24, 2025, Surgery Partners, Inc. has a mildly bearish trend influenced by mixed technical indicators, outperforming the S&P 500 recently but significantly underperforming over the long term.
Is Surgery Partners, Inc. technically bullish or bearish?
As of October 24, 2025, Surgery Partners, Inc. shows a mildly bearish trend with mixed signals across various indicators, including bearish MACD and KST readings, while Bollinger Bands present a bullish outlook on the weekly timeframe.
Is Surgery Partners, Inc. technically bullish or bearish?
As of October 24, 2025, Surgery Partners, Inc. shows a mildly bearish trend with mixed technical indicators, including a bearish weekly MACD and a mildly bullish monthly MACD, while outperforming the S&P 500 recently but underperforming over the past year.
Surgery Partners, Inc. Experiences Revision in Stock Evaluation Amid Market Volatility
Surgery Partners, Inc. has recently revised its evaluation amid fluctuating market conditions. The stock is currently priced at $20.39, showing volatility in trading. Over the past year, it has significantly underperformed compared to the S&P 500, indicating ongoing challenges for the company in the hospital industry.
Is Surgery Partners, Inc. technically bullish or bearish?
As of October 3, 2025, Surgery Partners, Inc. is in a mildly bearish trend, indicated by bearish signals in MACD and Bollinger Bands, despite a mildly bullish KST signal, and has significantly underperformed the S&P 500 with a 1-year return of -34.56%.
Is Surgery Partners, Inc. technically bullish or bearish?
As of October 3, 2025, Surgery Partners, Inc. exhibits a mildly bearish technical trend, with conflicting indicators across different time frames and a significant underperformance compared to the S&P 500.
Is Surgery Partners, Inc. technically bullish or bearish?
As of October 3, 2025, Surgery Partners, Inc. has a mildly bearish trend, indicated by bearish MACD and moving averages, with a 1-year return of -32.19% compared to the S&P 500's 17.82%.
Surgery Partners, Inc. Experiences Revision in Stock Evaluation Amid Market Performance Shifts
Surgery Partners, Inc. has recently adjusted its market performance metrics, with its stock price at $21.85. The company has experienced significant volatility over the past year, with a 52-week high of $33.37 and a low of $18.87, reflecting challenges in a competitive market.
Surgery Partners, Inc. Experiences Revision in Stock Evaluation Amid Market Volatility
Surgery Partners, Inc. has recently revised its evaluation amid market fluctuations, with its stock showing significant volatility over the past year. Technical indicators present a mixed performance, and the company has struggled to match the returns of the S&P 500, highlighting ongoing challenges in a competitive environment.
Is Surgery Partners, Inc. technically bullish or bearish?
As of September 10, 2025, Surgery Partners, Inc. has a bearish technical trend with weak strength, indicated by bearish daily moving averages and monthly MACD, while the stock has declined 31.50% over the past year, underperforming the S&P 500's 17.14% gain.
Is Surgery Partners, Inc. overvalued or undervalued?
As of August 6, 2024, Surgery Partners, Inc. is considered a risky investment due to its overvaluation indicated by a high P/E ratio of 39 compared to the peer average of 31.47, a lower ROE of 4.40% than the industry average, and significant underperformance against the S&P 500.
Is Surgery Partners, Inc. overvalued or undervalued?
As of August 6, 2024, Surgery Partners, Inc. is considered overvalued with a high P/E ratio of 39 and low ROE of 4.40%, significantly lagging behind industry peers and the S&P 500, leading to a shift in its valuation grade from very attractive to risky.
Is Surgery Partners, Inc. technically bullish or bearish?
As of June 17, 2025, Surgery Partners, Inc. is in a bearish trend, indicated by negative MACD readings, a bearish moving average, and underperformance against the S&P 500.
Who are in the management team of Surgery Partners, Inc.?
As of March 2022, the management team of Surgery Partners, Inc. includes Executive Chairman Wayne DeVeydt, CEO J. Eric Evans, and several independent directors: Clifford Adlerz, John Deane, Teresa DeLuca, Andrew Kaplan, and T. Devin O'Reilly. They oversee the company's operations and strategic direction.
What does Surgery Partners, Inc. do?
Surgery Partners, Inc. is a small-cap healthcare services company in the hospital industry, with recent net sales of $776 million and a market cap of approximately $2.61 billion. Key financial metrics include a P/E ratio of 39.00 and a debt-to-equity ratio of 1.43.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
